Drug & Medication Database

Dosage form: POWDER. Active ingredients: LOSARTAN POTASSIUM (1 kg/kg). Category: BULK INGREDIENT.

Losartan potassium and hydrochlorothiazide is a combination tablet containing an angiotensin II receptor blocker and a diuretic for the treatment of hypertension and reduction of stroke risk.

Brands: Losartan Potassium And Hydrochlorothiazide

Dosage form: GRANULE. Active ingredients: LOSARTAN POTASSIUM (.0333 kg/kg). Category: DRUG FOR FURTHER PROCESSING.

Loteprednol etabonate is a sterile topical anti-inflammatory corticosteroid for ophthalmic use containing 0.5% loteprednol etabonate, indicated for steroid-responsive inflammatory conditions of the eye.

Brands: Loteprednol Etabonate

11 DESCRIPTION Loteprednol Etabonate and Tobramycin Ophthalmic Suspension is a sterile, multiple dose topical anti-inflammatory corticosteroid and anti-infective combination for ophthalmic use. Both loteprednol etabonate and tobramycin are white to off-white powders. The chemical structures of loteprednol etabonate and tobramycin are shown below.

Brands: Loteprednol Etabonate And Tobramycin

Dosage form: POWDER. Active ingredients: LOTILANER (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION Lotilaner is a member of the isoxazoline family of compounds. Its chemical name is 2-Thiophenecarboxamide, 5-[(5S)-4,5-dihydro-5-(3,4,5-trichlorophenyl)-5-(trifluoromethyl)-3-isoxazolyl]-3-methyl-N-[2-oxo-2-[(2,2,2-trifluoroethyl)amino]ethyl]-2-thiophenecarboxamide. The molecular formula is C 20 H 14 Cl 3 F 6 N 3 O 3 S. The molecular weight is 596.76 g/mol.

Brands: Xdemvy

Dosage form: TABLET, CHEWABLE. Active ingredients: LOTILANER (225 mg/1); MOXIDECTIN (.225 mg/1); PRAZIQUANTEL (57 mg/1); PYRANTEL PAMOATE (57 mg/1). Category: DRUG FOR FURTHER PROCESSING.

Antimicrobial

Brands: Hand

Purpose Antiseptic

Brands: Hand Sanitizer

DESCRIPTION Lovastatin is a cholesterol lowering agent isolated from a strain of Aspergillus terreus. After oral ingestion, lovastatin, which is an inactive lactone, is hydrolyzed to the corresponding β-hydroxyacid form. This is a principal metabolite and an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. This enzyme catalyzes the conversion of HMG-CoA to mevalonate, which is an early and rate limiting step in the biosynthesis of cholesterol.

Brands: Lovastatin

Dosage form: INJECTION, SUSPENSION. Active ingredients: LOVOTIBEGLOGENE AUTOTEMCEL (1 g/mL). Category: DRUG FOR FURTHER PROCESSING.

11 DESCRIPTION LYFGENIA (lovotibeglogene autotemcel) is a β A-T87Q -globin gene therapy consisting of autologous CD34+ cells from patients with sickle cell disease containing hematopoietic stem cells (HSCs) transduced with BB305 LVV encoding β A-T87Q -globin, suspended in cryopreservation solution. LYFGENIA is intended for one-time administration to add functional copies of a modified form of the β-globin gene (β A-T87Q -globin gene) into the patient's own HSCs.

Brands: Lyfgenia

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Low Back Pain Drops 2041

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Low Bacterial Nosode 4022

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Low Bowel Pathogen Nosode 4025

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Low Hepatitis Nosode 4026

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Low Mycosis Nosode 4021

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Low Periodontal Nosode 4027

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Low Vaccinosis Nosode 4024

*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

Brands: Low Virus Nosode 4023

DESCRIPTION Loxapine, a dibenzoxazepine compound, represents a subclass of tricyclic antipsychotic agents, chemically distinct from the thioxanthenes, butyrophenones, and phenothiazines. Chemically, it is 2-Chloro-11-(4-methyl-1-piperazinyl)dibenz[ b,f ][1,4]oxazepine. It is present as the succinate salt. Each capsule for oral administration, contains loxapine succinate, USP 6.8 mg, 13.6 mg, 34.0 mg or 68.1 mg equivalent to 5 mg, 10 mg, 25 mg or 50 mg of loxapine base respectively.

Brands: Loxapine

Manufactured by ACTAVIS LABS UT INC. Dosage form: INJECTABLE. Route: INJECTION. Active ingredients: LOXAPINE HYDROCHLORIDE (EQ 50MG BASE/ML). Application: NDA018039.

Dosage form: POWDER. Active ingredients: LOXAPINE SUCCINATE (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: SELPERCATINIB (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: LOXOPROFEN (1 kg/kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: LOXOPROFEN SODIUM DIHYDRATE (25 kg/25kg). Category: BULK INGREDIENT.

Dosage form: POWDER. Active ingredients: LUBABEGRON FUMARATE (1 kg/kg). Category: BULK INGREDIENT.

11 DESCRIPTION Lubiprostone is a chloride channel activator for oral use. The chemical name for lubiprostone is (–)-7-[(2 R ,4a R ,5 R ,7a R )-2-(1,1-difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta[ b ]pyran-5-yl]heptanoic acid.

Brands: Lubiprostone

Dosage form: SOLUTION, CONCENTRATE. Active ingredients: LUBIPROSTONE (24 mg/g). Category: DRUG FOR FURTHER PROCESSING.